Renasant Corp: Form 10-K for the period ended Dec 31, 2023
Filed with the SEC on Feb 23, 2024 and accepted by EDGAR at Feb 23, 2024, 16:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $278.0m | us-gaap:InterestExpense |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $32.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | $144.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | $2.56 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | $2.58 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 56,448,163 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $148.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $21.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2023-01-01 to 2023-12-31 | $50.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2023-01-01 to 2023-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $801.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2023-12-31 | $17.36bn | us-gaap:Assets |
| Total liabilities | At period end2023-12-31 | $15.06bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $429.4m | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2023-12-31 | $307.6m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-12-31 | $2.30bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000715072-24-000042. Last ingested by Listed: Oct 29, 2026, 04:33 ET. Listed shows no prices and gives no investment advice.